Prior therapy with antiplatelet agents is not associated with outcome in patients with acute ischemic stroke/TIA

Journal of Neurology

Volumn 253, Issue 5, 2006, Pages 648-652

  Greisenegger, S ^a   Tentschert, S ^a   Weber, M ^a   Ferrari, J ^b   Lang, W ^b   Lalouschek, W ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

Author keywords

Antiplatelet agents; Stroke; Stroke outcome

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; TICLOPIDINE;

ANALYSIS OF VARIANCE; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RATING SCALE; STATISTICAL SIGNIFICANCE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

AGED; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PLATELET AGGREGATION INHIBITORS; RECURRENCE; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 33745021663     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0088-0     Document Type: Article

References (17)

1. Bhatt DL, Topol EJ, on behalf on the CHARISMA Executive committee (2004) Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Am Heart J 148:263-268
2. Blake AD (2004) Dipyridamole is neuroprotective for cultured rat embryonic cortical neurons. Biochem Biophys Res Commun 314:501-504
3. Carolei A, Prencipe M, Fiorelli M, Fieschi C (1986) Severity of stroke and aspirin. Neurology 36:1010-1011
4. De Keyser J, Herroelen L, De Klippel N (1997) Early outcome in acute ischemic stroke is not influenced by the prophylactic use of low-dose aspirin. J Neurol Sci 145:93-96
5. Farinelli SE, Greene LA, Friedman WJ (1998) Neuroprotective actions of dipyridamole on cultured cns neurons. J Neurosci 18:5112-5123
6. Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W (2004) Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke 35:1688-1691
7. Grilli M, Pizzi M, Memo M, Spano P (1996) Neuroprotection by aspirin and sodium salicylate through blockade of nf-kappa-b activation. Science 274:1383-1385
8. Grotta JC, Lemak NA, Gary H, Fields WS, Vital D (1985) Does platelet anti-aggregant therapy lessen the severity of stroke? Neurology 35:632-636
9. Joseph RHE, Grunfeld S, Welch KMA (1989) Prior use of aspirin may reduce stroke severity. Ann Neurol 26:131
10. Kalra L, Perez I, Smithard DG, Sulch D (2000) Does prior use of aspirin affect outcome in ischemic stroke? Am J Med 108:205-209
11. Karepov V, Bornstein NM, Hass Y, Korczyn AD (1997) Does daily aspirin diminish severity of first-ever stroke? Arch Neurol 54:1369-1371
12. Lalouschek W, Lang W, Müllner M, on behalf of the Vienna Stroke Study Group (2001) Current strategies of secondary prevention after a cerebrovascular event - the Vienna stroke registry. Stroke 32:2860-2866
13. Lang W, Lalouschek W (2001) The Vienna Stroke Registry - objectives and methodology. Wien Klin Wochenschr 113:141-147
14. Quinn MJ, Bhatt DL, Zidar F, Vivekananthan D, Chew DP, Ellis SG, Plow E, Topol EJ (2004) Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention. Am J Cardiol 93:679-684
15. Rosenblum WI, El-Sabban F (1977) Platelet aggregation in the cerebral microcirculation: Effect of aspirin and other agents. Circ Res 40:320-328
16. Sivenius J, Cunha L, Diener HC, Forbes C, Laakso M, Lowenthal A, Smets P, Riekkinen P (1999) Antiplatelet treatment does not reduce the severity of subsequent stroke. European stroke prevention study 2 working group. Neurology 53:825-829
17. Wilterdink JL, Bendixen B, Adams HP Jr, Woolson RF, Clarke WR, Hansen MD (2001) Effect of prior aspirin use on stroke severity in the trial of org 10172 in acute stroke treatment (TOAST). Stroke 32:2836-2840